State Medicaid drug coverage would be restricted by per capita cap, governors' aides tell ASCP.
Executive Summary
MEDICAID CAP WOULD THREATEN WISCONSIN COGNITIVE SERVICES PROGRAM, a staffer to Wisconsin Gov. Tommy Thompson (R) told an American Society of Consultant Pharmacists conference March 18 in Washington, D.C. Wisconsin's state Medicaid program is "working with our pharmacists to make sure that people understand how to take their medications. We are trying to prevent misuse of medications," federal liaison Mary Catherine Mantho noted. Mantho predicted that "innovations like that will stop if there is a cap on the program." President Clinton's FY 1998 budget request proposes a per capita cap on Medicaid spending increases ("The Pink Sheet" Feb. 17, p. 3).
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth